04:07 PM EDT, 10/10/2024 (MT Newswires) -- Robert I Blum, Director, President & CEO, on October 09, 2024, sold 5,000 shares in Cytokinetics ( CYTK ) for $278,050. Following the Form 4 filing with the SEC, Blum has control over a total of 401,622 shares of the company, with 397,456 shares held directly and 4,166 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000112760224025384/xslF345X05/form4.xml